Clinical Trials

NCT06324357 | RECRUITING | PHASE1/PHASE2
768 participants

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-06
Start Date:
2024-06-28
Completion:
2029-01-08
Conditions
  • Metastatic Breast Cancer
  • Metastatic Gastric Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma
  • Esophageal Adenocarcinoma
  • Colorectal Cancer
Interventions
  • DRUG
No Results Yet
NCT06287151 | COMPLETED | NA
80 participants

Regional Anesthesia EMG Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-06
Start Date:
2023-08-09
Completion:
2025-02-28
Conditions
  • Surgery
Interventions
  • DEVICE
  • DRUG
No Results Yet
NCT06223789 | COMPLETED | NA
392 participants

VOLT-AF IDE Clinical Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-06
Start Date:
2024-04-03
Completion:
2025-10-03
Conditions
  • Atrial Arrhythmia
  • Atrial Fibrillation
  • Paroxysmal Atrial Fibrillation
  • Persistent Atrial Fibrillation
Interventions
  • DEVICE
No Results Yet
NCT06212570 | NOT_YET_RECRUITING | NA
12 participants

KeyScope Study in Uganda

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-06
Start Date:
2026-09-01
Completion:
2027-06-30
Conditions
  • Abdominal Neoplasm
Interventions
  • DEVICE
No Results Yet
NCT06176261 | RECRUITING | PHASE2
58 participants

DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-06
Start Date:
2024-01-08
Completion:
2028-01-01
Conditions
  • Breast Cancer
  • Breast Cancer Female
  • Metastatic Triple-Negative Breast Carcinoma
  • ER Positive Breast Cancer
  • HER2-negative Breast Cancer
  • HER2 Negative Breast Carcinoma
  • ER-negative Breast Cancer
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page